The mean (+ s.e.m.) change of CD169 expression levels on CD14⁺ monocytes in blood of rhesus macaques stratified by time of cART initiation. by Brandon F. Keele (7450001)

SIV CA-DNA, SIV CA-RNA, and IPDA levels prior to ART interruption using CA-DNA and RNA values and IPDA. by Brandon F. Keele (7450001)

CA-RNA and CA-DNA viral load measurements from PBMC, peripheral LNMCs, DUO and BM from 3, 70, and 250 dpi. by Brandon F. Keele (7450001)

Early pre- and post-ART plasma viral load dynamics of individual RMs. by Brandon F. Keele (7450001)

Delay in first phase viral decay kinetics when ART is started pre-peak. by Brandon F. Keele (7450001)

Pre-ART plasma barcode proportion during primary infection. by Brandon F. Keele (7450001)

SRPO significantly decreased leukocyte-endothelial interactions and serum MCP-1 level. by Hiroshi Kataoka (270804)

Split <i>ClvR</i>^<50cM configurations. by Georg Oberhofer (3401438)

Representative gating strategy of SARS-CoV-2 peptide stimulated PBMC analysis by flow cytometry. by Katherine M. Littlefield (12647420)

Cumulative and S-, N- and M- specific SARS-CoV-2 specific T cell frequencies are elevated in PASC. by Katherine M. Littlefield (12647420)

Cytokine co-expression of SARS-CoV-2 specific T cells differs between PASC and RC. by Katherine M. Littlefield (12647420)

Decreased production of highly reactive oxygen species production induced by complement-mediated phagocytosis in Rab27a-knockdown cells. by Tatsumi Kawakami (505540)

Decreased expression of RRIowa_1520 by <i>R. rickettsii</i> Iowa. by Adam M. Nock (16715671)

Genes correlated with SARS-CoV-2 viral load over time are similarly expressed in independent datasets of SARS-CoV-2 infected lung and upper airway cells. by Vasanthi Avadhanula (259546)

“…<b>(c)</b> Similar to part b, but for genes decreased with SARS-CoV-2 infection.</p>…”

Elemental analysis shows a decreased N content in N stressed cells without a change in their C content. by Steve Dagenais Bellefeuille (654383)

Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

“…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”

Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

“…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”

Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

“…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”

Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

“…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”

Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications by Karel J. Hartlieb (1367880)

“…Although many promising chemotherapeutics have been developed upon the basis of polyaromatic DNA intercalating systems, these candidates did not proceed past clinical trials on account of their dose-limiting toxicity. Herein, we discuss an alternative, water-soluble class of polyaromatic compounds, the 2,9-diazaperopyrenium dications, and report <i>in vitro</i> cell studies for a library of these dications. …”